Novaliq
PrivateLast Round
VC Round
Oct 11, 2018
Total Funding Raised
$17.8M
Company Overview
Novaliq is a biopharmaceutical company that develops and commercializes ocular therapeutics based on its proprietary EyeSol® water-free technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novaliq Comparables
Compare Novaliq with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bausch + Lomb Corporation | 84% | |
| Harrow, Inc. | 79% | |
| Aldeyra Therapeutics | 76% |
Novaliq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 11, 2018 | ||||
| VC Round | Apr 11, 2013 | ||||
| VC Round | May 4, 2012 | ||||
| VC Round | Jul 27, 2011 |
Key People
Founding team and executive leadership
Novaliq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dievini Hopp BioTech holding | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
EyeSol technology drug approved in China in 2025.
- Jan 1, 2024
EyeSol technology drug received regulatory approval in Europe in 2024.
Novaliq Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Novaliq's valuation, stock price, and market status.
Is Novaliq a public or private company?
Novaliq is a private company.
What is the current stock price of Novaliq?
Novaliq is a private company with no public stock price. No recent secondary market data is available.
How much is Novaliq worth (valuation)?
Valuation information for Novaliq is not publicly available.
Can I buy Novaliq stock?
Novaliq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Novaliq's last funding round?
Novaliq's most recent funding round was Series C on October 11, 2018.
Who are the main investors in Novaliq?
Investor information for Novaliq is not publicly disclosed.
Will Novaliq IPO soon?
No public IPO plans have been announced for Novaliq.
How can I track Novaliq secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novaliq's secondary market activity and sign up for updates.